Volume | 2,796,519 |
|
|||||
News | (1) | ||||||
Day High | 78.52 | Low High |
|||||
Day Low | 76.50 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
GE HealthCare Technologies Inc | GEHC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
76.58 | 76.50 | 78.52 | 76.24 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
43,323 | 2,796,519 | $ 77.65 | $ 217,160,140 | - | 62.35 - 94.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:28:38 | 5 | $ 77.84 | USD |
GE HealthCare Technologies (GEHC) Options Flow Summary
GE HealthCare Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
35.55B | 455.36M | - | 19.55B | 1.39B | 3.04 | 25.67 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
GE HealthCare Technologies News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GEHC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 86.11 | 89.18 | 76.08 | 80.72 | 4,784,296 | -8.28 | -9.62% |
1 Month | 88.10 | 90.84 | 76.08 | 84.33 | 3,000,911 | -10.27 | -11.66% |
3 Months | 82.04 | 94.50 | 76.08 | 87.39 | 3,599,482 | -4.21 | -5.13% |
6 Months | 66.75 | 94.50 | 66.00 | 80.97 | 3,136,563 | 11.08 | 16.60% |
1 Year | 81.07 | 94.50 | 62.35 | 77.51 | 3,117,935 | -3.24 | -4.00% |
3 Years | 54.13 | 94.50 | 53.813 | 75.83 | 3,090,561 | 23.70 | 43.78% |
5 Years | 54.13 | 94.50 | 53.813 | 75.83 | 3,090,561 | 23.70 | 43.78% |
GE HealthCare Technologies Description
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. |